_ataxia-telangiectasia-overview-and-immunologist-role.jpg "Ataxia-telangiectasia: overview and immunologist role from ataxia telangiectasia Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 50 min 36 sec
✓ Published: 21-Jun-2023
✓ Published: 21-Jun-2023
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_lee.webp "Ataxia telangiectasia is a rare neurodegenerative disease, one that has left Lee severely disabled. But not one that makes him sad or unhappy with life, as thankfully he has a family who care and are there for him and all his needs… Meet Lee and A.T.")
_silicon-valley-prayer-breakfast-2010-03-31.webp "The 2010 event featured Joe Ehrmann, former NFL player, coach, and community leader, and Tim Borland, president of Race for Good. The theme of the event was")
_imagin-at-film.webp "Dr Jayesh Bhatt and Dr Andrew Prayle talk about their IMAGIN-AT research project at Nottingham University Hospital")
_causes-and-drug-development-in-ataxia-telangiectasia.webp "Dr Richard Gatti meets with ecancertv to discuss Ataxia telangiectasia (AT), a rare, and some times lethal, disorder in children where one out of three develops malignancy by the age of ten.nnDr Gatti notes that children with AT have a very strong cancer predisposition because they are missing the ATM protein which causes cell death by apoptosis; however, it is still unclear has to how this results in the development of cancer cells. Dr Gatti is currently working on the development of a group of")
_longitudinal-brain-changes-in-childhood-a-t.webp "Dr Rob Dineen talks about his latest Ataxia Telangiectasia (A-T) research project at the University of Nottingham.")
_combination-of-camonsertib-plus-parpi-shows-clinical-activity-in-ddr-aberrant-tumours.webp "Dr Timothy Yap speaks to ecancer about the safety and efficacy of three PARP inhibitors combined with the ataxia telangiectasia- and Rad3-related kinase inhibitor camonsertib, in patients with solid tumours harbouring DNA damage response alterations.nnThe study explored patients (≥ 18 yrs) with relapsed/refractory solid tumours with DDR alterations which were treated with camonsertib plus talazoparib, niraparib, or olaparib in 2 phase I trials.nnThe combination of camonsertib plus PARPi at low")
⏲ 3 min 28 sec ✓ 21-Apr-2023
_identifying-new-therapies-for-blood-cancers-in-patients-with-a-t.webp "Research project at the University of Birmingham to identify new therapies for treating blood cancers in patients with Ataxia Telangiectasia (A-T)")
_at-society-music-video-trailer.webp "Highlights from the AT Society Adult Weekend. The full documentary of the weekend will follow later in 2016. In the meantime, watch our trailer.nnA-T SocietynQuality of life and quality of care for everyone living with Ataxia-Telangiectasianwww.atsociety.org.uk/donate")
_lee.jpg)
_silicon-valley-prayer-breakfast-2010-03-31.jpg)
_imagin-at-film.jpg)
_causes-and-drug-development-in-ataxia-telangiectasia.jpg)
_longitudinal-brain-changes-in-childhood-a-t.jpg)
_combination-of-camonsertib-plus-parpi-shows-clinical-activity-in-ddr-aberrant-tumours.jpg)
_identifying-new-therapies-for-blood-cancers-in-patients-with-a-t.jpg)
_at-society-music-video-trailer.jpg)
![[+]](/images/menu.gif){kind=small}